Clinical trial
Comparison of ultraSound, Abbreviated MRI witH and Without HBP aS mOdalities for HCC suRveillance in patienTs With High Risk: a Multi-centers, Randomized Controlled Open-label Trial
NCT07010588 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of ultraSound, Abbreviated MRI witH and Without HBP aS mOdalities for HCC suRveillance in patienTs With High Risk: a Multi-centers, Randomized Controlled Open-label Trial
- Lead sponsor
- Peking University People's Hospital
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- June 30, 2025
- Completion date
- June 30, 2030
- Enrollment
- 1,389 (estimated)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.
hepatocellular carcinoma (hcc), magnetic resonance imaging (mri), randomized controlled trial